Filter posts

Morning Consult: Right-Sized Regulations, Innovation and Investor Protection

Today, an op-ed from BIO President and CEO Jim Greenwood appeared in Morning Consult stressing …

Tick Size Pilot Program: A Few Pennies Make a Big Difference

Earlier this week, the Securities and Exchange Commission (SEC) approved a tick size pilot program …

IP Sessions at the 2015 BIO International Convention

This year’s BIO International Convention will be host to educational sessions on the latest issues …

Innovation Files: CSBI Tax Proposals Attempt to Bridge “Valley of Death”

Over at the Innovation Files, Joe Kennedy has posted an excellent summary of a set …

BIO Deputy General Counsel Testifies on Patent Reform

On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front …

Blue Ribbon Study Panel Examines Surveillance and Detection Issues in Biodefense

The Blue Ribbon Study Panel on Biodefense held the third of four meetings on Thursday, …

BIO Chair Testifies Before Senate

BIO’s Chair and CEO of GlycoMimetics, Rachel King, testified before the Senate Committee on Small …

BIO and University Organizations offer Support of STRONG Patents Act

On March 4, 2015, Senator Chris Coons (D-DE) introduced a new bill, The STRONG Patents …

We Need Your Input: BIO Survey on Effective FDA-Sponsor Communication

BIO is surveying members and non-members on their interactions with the FDA during the various …

BIO IPCC Spring Conference Program Announced

BIO’s 2015 IP Counsels Committee Spring Conference & Meeting will be held April 15-17 in …